VMValeriy A. Mukhortykh

Valeriy A. Mukhortykh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Valeriy A. Mukhortykh has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Risk factors for lipid metabolism disorders in underage athletes: A review

    by A. V. Krutova, V. А. Mukhortykh, T. A. Kiseleva, I. V. Zyabkin

  • Open Access

    Platelet‑rich plasma enhances quality of life in adolescent athletes with major joint injuries

    by I. V. Zyabkin, E. V. Zavaleva, A. M. Kovalkova, V. A. Mukhortykh, I. V. Pankratov, И. В. Зябкин, Е. В. Завалева, А. М. Ковалькова, В. А. Мухортых, И. В. Панкратов

    Platelet‑rich plasma enhances quality of life in adolescent athletes with major joint injuries | Zyabkin | Extreme Medicine Применение обогащенной тромбоцитами плазмы позволяет повысить качество жизни несовершеннолетних спортсменов с травмами крупных суставов | Зябкин | Экстремальная биомедицина

  • The role of polyunsaturated fatty acids in the development of allergic diseases

    by Valeriy A. Mukhortykh, Inna A. Larkova, Nataliya A. Tarmaeva, Vera A. Revyakina

    Introduction. The steady increase in the prevalence and severity of allergic diseases worldwide necessitates the search for new pathogenetic mechanisms and preventive strategies. In addition to genetic predisposition, environmental factors, particularly the nature of nutrition during critical periods of early ontogenesis, have a significant impact on the development of the immune response and the risk for atopy. Polyunsaturated fatty acids (PUFAs) play a central role in this process, and the imbalance between the consumption of pro-inflammatory omega-6 and anti-inflammatory ω-3 PUFAs is considered a key factor in the epidemiology of allergic diseases. The aim. To systematize current data on the role and mechanisms of the effect of long-chain PUFA on the risk of development and course of allergic diseases, as well as to assess the potential for their use in prevention and therapy, taking into account genetic features of metabolism.Materials and methods. The analysis of data from epidemiological, observational, and intervention studies, as well as systematic reviews, devoted to the study of the relationship between the consumption of PUFAs (both with food and in the form of supplements) during pregnancy, lactation, and early childhood with markers of immune response and clinical outcomes of allergic diseases. Special attention is paid to the role of polymorphisms of genes of the FADS cluster (FADS1, FADS2), encoding desaturase enzymes, in the modulation of the effects of PUFAs.Results. The biological effects of ω-6 (arachidonic acid, ArA) and ω-3 (eicosapentaenoic acid, EPA and docosahexaenoic acid, DHA) PUFA were established to be opposite. ARA metabolites (prostaglandins, leukotrienes) provoke and support allergic inflammation, promote the polarization of the Th2-type immune response and IgE synthesis. On the contrary, ω-3 PUFAs compete with arcs for enzymes, suppressing the synthesis of pro-inflammatory eicosanoids and promoting the formation of specialized resolving mediators (SRM) that resolve inflammation and promote the formation of immune tolerance. Taking ω-3 PUFA supplements during pregnancy and lactation has been shown to be associated with a reduced risk of atopic dermatitis, sensitization to food allergens (especially egg white) and bronchial asthma in children, and the effects can persist for many years. The enrichment of infant formula with PUFA brings their immunomodulatory properties closer to those of breast milk. The effectiveness of PUFA interventions significantly depends on the genetic profile. Carriers of minor alleles of polymorphisms of the FADS genes are characterized by reduced desaturase activity, which leads to lower baseline concentrations of PUFA (especially ARA) and, as a result, to a greater susceptibility to the positive effects of supplementation of ω-3 PUFA and to a potentially lower risk of developing allergies mediated by reduced synthesis of proinflammatory mediators. The “genotype-diet” interaction is a critical factor: dietary interventions (for example, breastfeeding, increased consumption of fish) demonstrate the most pronounced protective effect in carriers of certain genotypes. At the same time, the data from individual studies are contradictory, which may be due to differences in research design, dosages, initial nutritional status of participants and their genetic background.Conclusion. Long-chain PUFA play a fundamental role in the modulation of immune processes underlying the pathogenesis of allergic diseases. ω-3 PUFA supplementation during the perinatal period and early childhood demonstrates significant potential for the primary prevention of atopy. However, further large-scale prospective studies are required to develop personalized recommendations, taking into account the genetic characteristics of PUFA metabolism (primarily, the FADS cluster polymorphisms), which will allow identifying target populations, optimal doses, timing, and duration of interventions to maximize their clinical effectiveness.Contribution: Mukhortykh V.A., Larkova I.A. — creation of the concept, construction of sections of the work; Mukhortykh V.A., Larkova I.A., Tarmaeva N.A. — work with literature sources, analysis and generalization of the data obtained, writing the text; Revyakina V.A. — editing the text. All co-authors — approval of the final version of the article, responsibility for the integrity of all parts of the article.Acknowledgment. The research work on the preparation of the manuscript was carried out using funds from a subsidy for the implementation of a state assignment within the framework of the Fundamental Scientific Research Program (FGMF-2025-0003).Conflict of interest. The authors declare no conflict of interest.Received: November 06, 2025Accepted: November 27, 2025Published: December 25, 2025

  • Open Access

    Injuries and damage to large joints in underage athletes. Therapy with platelet-rich plasma. A clinical case

    by I. V. Zyabkin, I. V. Pankratov, А. М. Ковалькова, V. V. Khizhnikova, E. V. Zavaleva, V. A. Mukhortykh

    Introduction . Approximately 46% of large joint injuries involve damage to the knee joint, among which anterior cruciate ligament (ACL) injuries account for about 15–24% in children and adolescents. In order to reduce the likelihood of long-term complications after injuries in underage professional athletes, shorten the rehabilitation period, and enable a quicker return to elite sports, innovative regenerative medicine technologies should be implemented into clinical practice, including the use of platelet-rich plasma (PRP). In comparison with other conservative treatment methods, PRP offers several advantages. Being an orthobiological agent, PRP is a biological substance derived from the patient’s own body, promoting accelerated regeneration with minimal risk of side effects. When performed correctly, this procedure shows minimal invasiveness and does not lead to complications. Although PRP therapy is widely used in treating diseases and injuries of large joints in adult patients, the application of this therapeutic method in underage athletes has not been sufficiently studied, which is the focus of this study. Case report . We present a clinical case of a professional athlete with a knee joint injury, assessing the functional and clinical outcomes of PRP therapy. Two standardized methods for PRP application are demonstrated, highlighting the advantages of a closed-loop PRP preparation system. These include minimized exposure to the external environment, mitigating potential risks of infection, and reduced consumption of materials, enhancing cost-effectiveness. The described clinical case of an ACL injury in a junior athlete, with complete functional and structural recovery (as confirmed by magnetic resonance imaging, MRI), demonstrated the efficacy, safety, and good tolerability of PRP therapy. Positive outcomes were observed both clinically (regression of pain assessed via the visual analog scale, restoration of joint function, and positive dynamics in provocative tests such as the Lachman test and anterior drawer test) and through MRI data. Conclusions. The use of PRP therapy for ACL injuries in underage professional athletes represents a promising therapeutic approach in orthopedics and sports medicine, utilizing regenerative medicine technologies. The closed-loop system for PRP preparation offers several advantages over open-loop systems, including cost-effectiveness due to minimized consumption of medical supplies. The safety of the method is ensured provided that the procedural requirements are met (asepsis, antisepsis, ultrasound guidance, etc.); the high sensitivity of MRI in tracking the dynamics of ACL injuries is confirmed.

  • Open Access

    Diagnostic features and management algorithm for children with dyslipidemia

    by Александра Владимировна Крутова, Valeriy A. Mukhortykh, Антон Сергеевич Мирошниченко, Svetlana A. Stolyarova, Iliya V. Zyabkin, Валерий Алексеевич Мухортых, Илья Владимирович Зябкин

    Introduction. Lipid metabolism disorders play a key role in the development of cardiovascular diseases (CVD). Hyperlipidemia, which occurred in childhood, continues to progress over adulthood, contributing to the development of atherosclerosis. The lack of screening for the lipid profile, clinical manifestations and low alertness of pediatricians, lead to late detection of this pathology and minimize the possibility of using a set of preventive measures. The aim of the review is to determine the features of the diagnosis of lipid metabolism disorders for the development of an algorithm for managing children with dyslipidemia. The material for the analysis was scientific reports selected in the MedLine, Google Scholar, and PubMed databases from 1980 to 2025. An effective way to diagnose dyslipidemia is screening, which should be performed at the age of 9–11 years and 17–21 years. Dyslipidemia is diagnosed when changes in two lipid profiles are detected. It is necessary to exclude primary hypercholesterolemia, which has an unfavourable course. Risk factors for atherosclerosis and early vascular diseases are analyzed to determine management tactics. The main method of correcting lipid metabolism disorders in children is lifestyle modification. In the absence of an effect, statins are indicated, which are the drug of choice in all developed countries. The efficacy and safety of long-term use of statins in children has been demonstrated. Early diagnosis and timely initiation of treatment of hyperlipidemia in children play a significant role in reducing the risk of atherosclerotic diseases over the old age.


  • Prognostic value of eosinophils in inflammatory bowel diseases in children

    by Svetlana Zaitseva, Elmira Alieva, Valery Mukhortykh, Saule Kosumova

    Inflammatory bowel diseases (IBD) include ulcerative colitis (UC) and Crohn's disease (CD), chronic inflammatory pathologies characterized primarily by lesions of the gastrointestinal tract (GIT). In recent decades, there has been an increase in the prevalence of IBD, which is associated with increased alertness of doctors and improved diagnostic methods. Endoscopic examination is of key importance in the diagnosis of these diseases, but more and more attention is being paid to histological examination. In biopsies from the intestinal mucosa, the crypt structure and cellular infiltrate are evaluated, which in IBD can be represented by various cells – lymphocytes, neutrophils and macrophages. Recently, increased attention has been paid to variants of inflammation, characterized mainly by eosinophilic infiltration. There is no unequivocal opinion on the effect of eosinophilic infiltration on the course, prognosis of the disease and the effectiveness of therapy in IBD. Given that eosinophils are actively involved in inflammation and the development of fibrosis in other diseases, it can be assumed that the eosinophilic variant of inflammation in the intestinal mucosa may be a prognostically significant factor determining the course of the disease and the choice of effective therapy. In this paper, the authors present their own observations on the relationship between eosinophilic infiltration of the intestinal mucosa and the course of IBD based on a retrospective assessment of the results of histological examination.

  • Open Access

    Evaluation of biomarkers of intestinal permeability and inflammation in food allergies

    by V.A. Revyakina, V.A. Mukhortykh, T.N. Korotkova, I.A. Larkova, I.V. Vorozhko, E.D. Kuvshinova

    Оценка биомаркеров проницаемости кишечника и воспаления при пищевой аллергии

  • Food allergy. Innovative methods of diagnosis and therapy

    by V.A. Revyakina, K.S. Melnikova, I.A. Larkova, V.A. Mukhortykh, E.D. Kuvshinova, N.A. Tarmaeva

    This review presents literature data on the prevalence of food allergy and food intolerance, clinical manifestations of IgE- and non-IgE-mediated immune reactions, as well as the results of our own research on the identification of causative food allergens using molecular diagnostics. Current approaches to diagnosis, diet therapy, and innovations in pharmacotherapy are described. Key words: food allergy, food intolerance, children, molecular diagnostics, diet therapy, biopharmaceuticals

  • Open Access

    Assessment of tolerance of a new product (gluten-free grain snack) in children with food allergy to gluten

    by V.A. Revyakina, E.M. Serba, V.A. Mukhortykh, I.A. Larkova, E.D. Kuvshinova, V.G. Dolzhenkova, A.Yu. Sharikov, M.V. Amelyakina

    Оценка переносимости нового продукта (безглютенового зернового снека) у детей с пищевой аллергией к глютену


  • Open Access

    Food allergy to cow’s milk proteins and meat

    by Vera A. Revyakina, Valeriy A. Mukhortykh, Инна Анатольевна Ларькова, Елена Дмитриевна Кувшинова, Валерий Алексеевич Мухортых

    Introduction. Cow’s milk and dairy products are important sources of high-quality animal proteins, calcium, vitamins, and minerals. They are widely used in the diet of preschool and school-age children and contribute to the normal development and resilience of children against the effects of adverse external factors. However, cow’s milk can cause serious allergic reactions in children, even leading to anaphylaxis. Allergy to cow’s milk proteins is one of the common allergic reactions among preschool-age children. Through conducted research, patterns of the natural course of milk allergy over time have been established. In most cases, by the age of 5 years, children develop tolerance to cow’s milk proteins. However, some school-age children may retain heightened sensitivity to them. Sustaining such prolonged milk allergy in a school-age child requires identifying the cause and conducting in-depth examinations for each specific patient. In such cases, valuable information about elevated sensitivity to whole cow’s milk protein and its components is provided by molecular (component-based) diagnostics. This enables the identification of causally significant components (α-lactalbumin, β-lactoglobulin, bovine serum albumin) of milk protein for the purpose of rational diet therapy, considering cross-reactions with beef meat. The presented article summarizes and systematizes literary and proprietary data on allergy to cow’s milk proteins and its components, as well as to beef meat. Understanding the characteristics of allergy to cow’s milk proteins and its components, cross-reacting with beef, will help avoid serious consequences of irrational elimination diets.